Embryo biopsy for PGT
During an embryo biopsy, roughly 5-10 cells are removed from the embryo’s trophectoderm. The biopsied sample is sent to a genetic testing company, while the embryo is typically frozen in the IVF lab. The genetic testing company analyzes the DNA in the biopsied sample and generates a report based on the analysis. The embryo can remain frozen in liquid nitrogen indefinitely.
Embryo biopsy is a crucial procedure in the field of assisted reproduction, particularly during in vitro fertilization (IVF). The process involves the extraction of cells from the embryo using a laser. This minimally invasive technique typically removes about 5-10 cells from the trophectoderm of the blastocyst stage embryo. The harvested cells are then analyzed by genetic testing companies to detect chromosomal abnormalities or specific genetic conditions, providing vital information for family planning. The embryos can be frozen for future use after the biopsy, allowing couples to make informed decisions based on the genetic findings. Embryo biopsy is often utilized in Preimplantation Genetic Testing (PGT), aimed at reducing the risk of genetic diseases and increasing the success rate of IVF. Given the emotional and physical investment in the IVF journey, understanding and considering embryo biopsy as part of the process can significantly benefit prospective parents, impacting not just the success of conception but also the health of the future child.
